10-K: USANA Health Sciences Reports Lower 2024 Sales and Earnings Amidst Challenging Economic Conditions

USANA Health Sciences' 2024 results reveal a decrease in net sales and earnings, impacted by economic headwinds and currency fluctuations, despite strategic efforts including the acquisition of Hiya Health Products.

Summary

• USANA Health Sciences reported net sales of $855 million for 2024, a 7.2% decrease compared to 2023.
• The decline in sales is attributed to a decrease in average customer spending and a reduction in active customers, influenced by challenging economic conditions.
• Currency exchange rate fluctuations negatively impacted net sales by an estimated $13.6 million.
• Net earnings attributable to USANA decreased by 34.1% to $42.0 million in 2024.
• The decrease in net earnings was primarily due to decreased sales, higher relative operating expenses, and a higher effective tax rate.
• The company acquired a 78.85% ownership interest in Hiya Health Products in December 2024, expanding into the direct-to-consumer channel.
• The company is focused on enhancing earning opportunities for associates, product development, brand strengthening, associate engagement, and regional support in 2025.
• The company plans to support and grow its acquired businesses, including Hiya, Rise, and Oola, and pursue further acquisition opportunities in the health and wellness space.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the acquisition of Hiya and strategic initiatives offer potential for future growth, the current financial results show a significant decline in sales and earnings, indicating a challenging operating environment. The sentiment is cautiously negative.

Positives

• The company acquired a 78.85% ownership interest in Hiya Health Products, expanding into the direct-to-consumer channel.
• Gross profit margin increased by 30 basis points to 81.1% of net sales.
• Associate incentives decreased 20 basis points to 42.6% of net sales.
• The company is focused on enhancing earning opportunities for associates, product development, brand strengthening, associate engagement, and regional support in 2025.
• The company plans to support and grow its acquired businesses, including Hiya, Rise, and Oola, and pursue further acquisition opportunities in the health and wellness space.
• The company remediated material weaknesses in internal control over financial reporting associated with information technology general controls (ITGCs).

Negatives

• Net sales decreased by 7.2% to $855 million in 2024.
• Net earnings attributable to USANA decreased by 34.1% to $42.0 million.
• Currency fluctuations negatively impacted net sales by an estimated $13.6 million.
• Selling, general and administrative expenses increased 280 basis points relative to net sales.
• Income taxes increased to 44.9% of pre-tax earnings in 2024, up from 37.7% of pre-tax earnings in 2023.
• Diluted earnings per share attributable to USANA decreased to $2.19 in 2024 from $3.30 in 2023.

Risks

• Direct selling is subject to intense government scrutiny, and regulation and changes in the law, or the interpretation and enforcement of the law, might adversely affect our business.
• The violation of marketing or advertising laws by Associates in connection with the sale of our products or the improper promotion of our Compensation Plan could adversely affect our business.
• Our Greater China region accounts for a significant part of our business and expected growth. A decline in sales or customers in this region would harm our business, financial condition and results of operations.
• Our operations in China are subject to significant government regulation, as well as a variety of legal, political, and economic risks.
• Risks associated with operating in international markets could restrict our ability to expand globally and harm our business and prospects.
• Fluctuation in the value of currency exchange rates with the U.S. dollar affects our operations and our net sales and earnings.
• Our products and manufacturing activities are subject to extensive government regulation, which could limit or prevent the sale of our products in some markets.
• If we are unable to attract and retain active Associates and Preferred Customers, our business may be harmed.
• Difficult economic conditions may adversely affect our business.
• Our business is subject to the effects of adverse publicity and negative public perception.

Future Outlook

In 2025, USANA will focus on enhancing earning opportunities for associates, accelerating product development, strengthening brand messaging, deepening associate engagement, focusing on China while implementing tailored regional solutions, and supporting acquired businesses.

Management Comments

• In 2025, we will continue executing on our global Associate-first growth strategy with a strong focus on increasing the number of active Customers in each of our markets.

Industry Context

The nutritional supplement industry is highly competitive with low barriers to entry, requiring companies to differentiate through product quality, scientific backing, and effective distribution strategies. USANA competes with both direct selling companies and traditional retail channels.

Comparison to Industry Standards

• USANA competes with other public and privately owned global network marketers for distributor talent, including for example Amway, Herbalife, and Nu Skin.
• On both fronts, compared to USANA, some of our competitors are significantly larger, have a longer operating history, higher visibility and name recognition, and greater financial resources.

Management Changes

Stakeholder Impact

• Shareholders may experience a decline in stock value due to decreased earnings.
• Associates may face challenges in earning potential due to lower sales and customer spending.
• Employees may be affected by cost-cutting measures or restructuring efforts.
• Customers may benefit from new product offerings and improved customer experience initiatives.

Next Steps

• The company will continue executing strategic initiatives to drive growth in China, including targeting and expanding a new customer demographic through simple, easy-to-use, digitally-based customer acquisition, fulfillment, and service initiatives.
• The company will continue to enhance our digital capabilities with continued investments aimed at improving the overall customer experience.
• The company will continue to expand our market-leading training, development, and certification programs to empower Associates in health, business, and personal growth, ensuring they have the tools needed to succeed.
• The company will continue to enhance our product portfolio with products specifically designed for the Chinese consumer.

Key Dates